Klivira
Request demo

Streamlining Infectious Disease Prior Authorization with Da Vinci PAS

Klivira's platform automates prior authorization for infectious disease treatments by leveraging Da Vinci PAS standards, ensuring efficient, structured data exchange for high-cost therapies.

For revenue cycle directors and prior authorization coordinators in infectious disease practices, managing PA for complex regimens like antivirals, antifungals, and OPAT presents significant operational burdens. The traditional workflow, reliant on disparate payer portals and fax, often delays patient access to critical treatments. Implementing Da Vinci PAS offers a pathway to standardize and accelerate these processes.

The Challenge of Infectious Disease Prior Authorization

Infectious disease (ID) prior authorization frequently involves high-cost medications such as antivirals (e.g., for HCV, HIV), antifungals, and outpatient parenteral antibiotic therapy (OPAT). Without a standardized approach, ID clinics face per-payer custom integrations, submitting unstructured clinical attachments via payer-specific portals (e.g., Availity, UHCprovider.com, CignaforHCP) or fax. This fragmentation leads to slow decision turnaround times, impacting patient care and increasing administrative overhead.

Transforming ID Prior Auth with Da Vinci PAS

The HL7 Da Vinci Project's Prior Authorization Support (PAS) implementation guide, built on HL7 FHIR R4, provides a standardized framework to automate and streamline the PA process. For infectious disease, this means moving beyond manual portal submissions and X12 278 EDI transactions that often rely on referenced PDF attachments. Da Vinci PAS enables structured clinical documentation and a consistent submission-response cycle, accelerating approvals for essential ID therapies.

Key Workflow Enhancements for Infectious Disease Practices

  • **Pre-PA Coverage Discovery**: Utilizing Da Vinci CRD at order entry for high-cost antivirals or OPAT, identifying PA requirements proactively.
  • **Structured Documentation Assembly**: Employing Da Vinci DTR questionnaires to gather and submit clinical data as structured FHIR resources, rather than PDFs, for conditions requiring detailed justification.
  • **Standardized PAS Submission**: Submitting `Claim` resources with structured clinical documentation via the payer's FHIR PAS endpoint, reducing manual data entry.
  • **Uniform Response Handling**: Receiving `ClaimResponse` resources with consistent approval, denial, or pending statuses, regardless of the payer, for regimens like HIV pre-exposure prophylaxis (PrEP) or complex antifungal courses.
  • **Automated Status Tracking**: Leveraging PAS inquiry operations or webhooks to monitor decision states for pending authorizations, minimizing staff follow-up calls.

Klivira's Da Vinci PAS Implementation for Infectious Disease

Klivira's platform provides a robust Da Vinci PAS client implementation tailored for infectious disease practices. Our system constructs and submits `Claim` resources to payer endpoints, integrating with EMRs via CDS Hooks for Da Vinci CRD at the point of order entry. For payers supporting DTR, we facilitate the assembly of structured clinical documentation, ensuring all necessary information for ID-specific treatments is captured efficiently. Klivira intelligently routes submissions, prioritizing PAS for conformant payers while falling back to X12 278 or provider portals for others, ensuring comprehensive coverage across the payer landscape.

Addressing ID-Specific Prior Authorization Failure Modes

Klivira's Da Vinci PAS implementation directly addresses common failure modes in infectious disease prior authorization. By replacing per-payer custom integration code paths with a uniform FHIR operation interface, we reduce IT burden. Structured documentation via DTR-driven questionnaires eliminates the ambiguity of PDF attachments for complex ID cases. The standardized `ClaimResponse` resource resolves inconsistent response semantics, providing a clear workflow state taxonomy for all ID-related PA decisions. This approach enables faster, more consistent processing for high-volume ID prior auth categories like antivirals, antifungals, and OPAT.

Navigating Payer Conformance and Regulatory Mandates

The regulatory landscape, specifically CMS-0057-F, mandates that impacted payers (Medicare Advantage, Medicaid managed-care, CHIP managed-care, and QHP-on-FFM) implement a FHIR-based Prior Authorization API by January 1, 2027. This aligns directly with Da Vinci PAS conformance. Klivira tracks per-payer applicability under CMS-0057-F, ensuring ID practices benefit from the phased timeline and associated requirements, such as the 72-hour standard and 24-hour expedited decision timeframes for medically urgent cases.

Frequently asked questions

How does Da Vinci PAS specifically benefit prior authorizations for OPAT in infectious disease?

For OPAT, Da Vinci PAS allows for the structured submission of clinical necessity documentation, such as patient stability, appropriate home care environment, and drug administration details, directly from the EMR via DTR. This eliminates the need for manual transcription or faxing of supporting clinical notes, accelerating payer review and approval for these critical outpatient therapies.

Can Klivira's Da Vinci PAS solution handle prior authorizations for both high-cost antivirals and HIV regimens?

Yes, Klivira's Da Vinci PAS solution is designed to handle prior authorizations for a broad range of high-cost infectious disease medications, including complex antiviral therapies for HCV, HIV regimens, and PrEP. The platform's ability to assemble and submit structured clinical documentation through FHIR ensures that the specific medical necessity criteria for these drugs are clearly communicated to payers, facilitating faster decisions.

What happens if an infectious disease payer is not yet Da Vinci PAS conformant?

Klivira's platform employs intelligent routing. For payers not yet conformant with Da Vinci PAS, our system automatically falls back to established channels such as X12 278 EDI transactions via clearinghouses or direct submission through payer-specific provider portals. This ensures that infectious disease prior authorizations continue without interruption, regardless of the payer's current technical capabilities.

How does Da Vinci CRD (Coverage Requirements Discovery) integrate with EMRs for infectious disease orders?

Klivira integrates Da Vinci CRD into the EMR's order entry workflow using CDS Hooks. When an infectious disease provider orders a medication or therapy requiring PA (e.g., a novel antifungal), CRD queries the payer in real-time. The EMR then displays structured `Claim` resources outlining specific PA requirements, allowing the provider to initiate the process or gather necessary documentation proactively, before the order is finalized.

Is Klivira's Da Vinci PAS implementation compliant with CMS-0057-F requirements for ID practices?

Klivira's implementation aligns with the technical specifications of Da Vinci PAS, which is the foundational standard for the Prior Authorization API mandated by CMS-0057-F. We track per-payer compliance status and ensure our platform supports the necessary FHIR-based data exchange for Medicare Advantage, Medicaid managed care, CHIP managed care, and QHP-on-FFM plans, helping ID practices meet regulatory expectations.

Related coverage

Other infectious-disease prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo